HOME >> BIOLOGY >> NEWS
Caterpillar saliva beats plant defenses

A common substance produced by fungi and other organisms has been found in the saliva of caterpillars and helps to suppress the toxins that plants produce when chewed on by insects, according to a team of entomologists. "The saliva of herbivorous insects has been overlooked as a factor in overcoming host defenses," the researchers report in today's issue of Nature. "Our results show that glucose oxidase, one of the principal components of Helicoverpa Zea saliva, is responsible for suppressing induced resistance in (tobacco)." Investigation of the caterpillar commonly known as corn earworm by a team of Penn State and University of Arkansas entomologists aimed at isolating the substance in caterpillar saliva that suppressed expression of defensive mechanisms in leaves. These defensive mechanisms include production of nicotine -- a neural toxin, and digestive protease inhibitors -- which interfere with caterpillar digestion. "Initially it was thought that caterpillar saliva contained only compounds that triggered the plant's defense mechanisms," says Dr. Gary W. Felton, head and professor of entomology at Penn State. "Rather than inducing defense mechanisms as we supposed, the saliva inhibits production of the harmful chemicals and actually weakens the defenses of the plant."

Felton, working with Richard O. Musser, the lead author on this paper and Sue M. Hum-Musser, graduate students at University of Arkansas; Herb Eichenseer, University of Arkansas post doctoral fellow now at Pioneer Seed Company, Gary Ervin, postdoctoral fellow now at Mississippi State University; and J. Brad Murphy, professor of horticulture, University of Arkansas; and Michelle Peiffer, research assistant, Penn State, identified glucose oxidase as an active ingredient of caterpillar saliva. Glucose oxidase converts the simple sugar glucose into gluconic acid and hydrogen peroxide.

"While glucose oxidase is produced in many biologic systems and glucose oxidase extracted from fung
'"/>

Contact: A'ndrea Elyse Messer
aem1@psu.edu
814-865-9481
Penn State
10-Apr-2002


Page: 1 2 3

Related biology news :

1. Caterpillars make noise to fend off intruders, researchers discover
2. Caterpillars foiled when tomato plants summon parasitic wasps
3. Oaks Defenses Help Gypsy Moth Caterpillar Fend Off Virus
4. Bone, enamel, dentine, milk & saliva share gene family
5. Bat saliva drug and new MRI techniques offer hope for acute stroke treatment
6. Tick saliva genes key to Lyme disease vaccine
7. UB dental researchers find novel peptide in saliva that kills broad range of fungi and bacteria
8. Component of fly saliva makes promising Leishmaniasis vaccine
9. White tea beats green tea in fighting germs
10. Virus beats food bug
11. Ramoplanin beats antibiotic resistance by fighting the battle on its own terms

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Caterpillar saliva beats plant defenses

(Date:2/5/2015)... , Jan. 26, 2015   Epic Sciences , a ... today announced that Murali Prahalad , Ph.D., president and ... World Conference (PMWC) 2015: Silicon Valley, which is taking ... View, Calif. on January 26-28, 2015. ... of Age as Biomarkers." Last year, Epic Sciences was a ...
(Date:2/5/2015)... 2015 New Market Research Reports ... Forecasts To 2020 has Been Added to GrandViewReseach.com Report ... expected to reach USD 5.10 billion by 2020, according ... IR cameras help identify the site of tissue damage ... surging demand in medical imaging applications. They have been ...
(Date:2/5/2015)... 30, 2015  It is gratifying to see that ... for genomic science as a means to better understand ... treatment.  I was honored to participate in today,s White ... program. Since the 1980s my teams ... the first sequenced genome of a free living organism, ...
Breaking Biology News(10 mins):Epic Sciences to Present at Personalized Medicine World Conference 2015 on the Use of Circulating Tumor Cells as Cancer Biomarkers 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 2IR Camera Market Worth $5.10 Billion By 2020: Grand View Research, Inc. 3J. Craig Venter, Ph.D., Co-Founder and CEO, Human Longevity, Inc. (HLI) Participates in White House Precision Medicine Event 2
(Date:2/27/2015)... CA (PRWEB) February 27, 2015 Cytokinetics, ... forces on February 28 with patients and health care ... awareness for Rare Disease Day®. Rare Disease Day ... and calling attention to the special challenges faced by ... them. , “Cytokinetics is proud to stand alongside patients ...
(Date:2/26/2015)... , Feb. 26, 2015 S&P Capital ... Factual Stock Report coverage on MabVax Therapeutics Holdings Inc ... is a clinical stage biotechnology company focused on the ... medical needs in the treatment of cancer. MabVax has ... on the protective immune responses generated by patients who ...
(Date:2/26/2015)... SQI Diagnostics Inc. ("SQI" or the "Company") (TSX-V: SQD; ... commercializes proprietary technologies and products for advanced microarray diagnostics, ... fiscal first quarter ended December  31, 2014. All figures ... unless otherwise stated. "During the quarter ... existing customers and add to our sales pipeline," said ...
(Date:2/26/2015)... Feb. 26, 2015 Protiviti ( www.protiviti.com ), ... of the Governance Portal , designed to increase ... compliance (GRC) tasks across multiple business units and projects. ... help customers better align their controls with the COSO ... ) requirements. In response to client feedback, Protiviti has ...
Breaking Biology Technology:Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 2Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 3Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 4Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 5Cytokinetics Joins Global Movement to Raise Awareness for Rare Diseases 6S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 2Protiviti Governance Portal Helps Companies Drive Governance, Risk and Compliance Productivity Across Multiple Business Units 3
Cached News: